Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NFLX vs MRNA✓SelectedUSD · MRNANFLX vs MRNA performance historyLatest closeAs of-2.96%11/20
Stock and ETF performance explorer

NFLX vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+114.0%
MRNA return
+786.4%
Excess return
-672.4%
Maximum drawdown
-75.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.0%-2.2%-0.8%-2.8%
7D-8.7%-12.7%+4.0%-8.1%
30D-12.8%-20.7%+7.9%-11.9%
3M-29.2%+46.3%-75.5%-31.0%
6M-35.6%+305.2%-340.8%-43.8%
YTD-39.5%+561.2%-600.7%-49.8%
1Y-46.3%+772.1%-818.4%-56.6%
3Y+19.6%+147.0%-127.4%+4.0%
5Y-16.4%-26.1%+9.6%-22.1%
All+114.0%+786.4%-672.4%+67.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling